The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sintilimab plus lenvatinib as conversion therapy in patients with unresectable locally intermediate to advanced hepatocellular carcinoma: A single-arm, single-center, open-label, phase 2 study.
 
Lijun Wang
No Relationships to Disclose
 
Hongwei Wang
No Relationships to Disclose
 
Yong Cui
No Relationships to Disclose
 
Kemin Jin
No Relationships to Disclose
 
Wei Liu
No Relationships to Disclose
 
Kun Wang
No Relationships to Disclose
 
Baocai Xing
No Relationships to Disclose